We are live on
!
Find out more
VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VC
1
Vivo Capital
Palo Alto,
California
| $17.7M | – | – | – |
|
|
O
2
OrbiMed
New York
| $14.8M | +$7.58M | +583,730 | +88% |
|
|
NMC
3
NEA Management Company
Timonium,
Maryland
| $14.5M | – | – | – |
|
|
VP
4
venBio Partners
San Francisco,
California
| $10.4M | +$11.4M | +875,000 | New |
|
|
NHAS
5
Novo Holdings A/S
Hellerup,
Denmark
| $8.79M | – | – | – |
|
|
FCMI
6
Foresite Capital Management III
Larkspur,
California
| $6.27M | -$1.04M | -80,429 | -13% |
|
|
TCM
7
Tekla Capital Management
Boston,
Massachusetts
| $3.28M | – | – | – |
|
|
PA
8
Perceptive Advisors
New York
| $2.38M | – | – | – |
|
|
PC
9
Polar Capital
London,
United Kingdom
| $1.13M | +$250K | +19,232 | +25% |
|
10
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $7K | +$7.79K | +600 | New |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| – | -$3K | -199 | Closed |
|
12
Morgan Stanley
New York
| – | +$13 | +1 | +7% |
|
13
UBS Group
Zurich,
Switzerland
| – | +$13 | +1 | New |
|